May 31, 2021
Scandal-racked generic maker Kobayashi Kako on May 28 submitted a business improvement plan to Japanese regulatory authorities over its fabricated drug filings, which resulted in the revocation of approvals for 12 products. The submission comes a month after the Ministry...read more